Admission Date:  [**2178-1-20**]              Discharge Date:   [**2178-1-23**]  Date of Birth:  [**2129-10-5**]             Sex:   F  Service: MEDICINE  Allergies: Zosyn / Quinolones / Ceftriaxone / Flagyl / Keppra / Lisinopril / Naprosyn / Bactrim DS / Phenytoin / Nitrofurantoin / Sulfa (Sulfonamide Antibiotics) / Zofran / IV Dye, Iodine Containing  Attending:[**First Name3 (LF) 6701**] Chief Complaint: Abdominal pain  Major Surgical or Invasive Procedure: None   History of Present Illness: This is a 48-year-old female with PMHx of spina bifida, HTN, MR, paraperesis, non-epileptic [**First Name3 (LF) 54422**], and urostomy with chief complaint of abdominal pain.
This occured 2 days prior to arrival, pain was diffuse (9.5/10), gradually increasing in severity.
Associated with: nausea and vomiting (food contents, non-bloody); patient denies f/c, new n/t/w, HA/neck pain, change in vision, CP, SOB, cough, change in BM (1 on day prior, non-bloody), GU s/sx.
Review of OMR reveals that the patient has been admitted several times for abdominal pain that presented similarly and had a negative work up including CT abdomen, RUQ U/S and HIDA scan.
Exam was notable for distended abdomen that was mildly distended diffusely tender to palpation.
Patient had Abd Xray and CT scan which were unremarkable (stool present, no SBO, no abscess, no pancreatitis or other acute process).
CXR showed no abnormality.
Patient given morphine x2 and Zofran and admitted for pain control.
Hypertension 3.
Urostomy 5. h/o VRE pyelonephritis 6.
Depression 9.
Mild mental retardation 10.
Psychogenic dysarthria and tremor 11.
Atopic dermatitis 13.
Back pain 14.
EXT: warm, well perfused 2+ distal pulses b/l NEURO: A&Ox3, able to answer questions appropriately  On transfer: VS: afebrile, BP 111/67, HR: 71, SP02: 100% RA General: Intubated, sedated Chest: Coarse breath sounds throughout, no crackles Cardiac: Regular rate and rhythm, no murmurs, rubs, or gallops Abd: +BS, well-healed surgical incision, soft   Pertinent Results: [**2178-1-22**] WBC-11.3*# Hgb-11.5* Hct-35.1* MCV-93 Plt Ct-226 Glucose-77 UreaN-9 Creat-0.8 Na-136 K-4.4 Cl-102 HCO3-25 Calcium-8.4 Phos-3.2 Mg-2.2 .
Baseline artifact in the limb leads makes assessment of those leads difficult.
CXR 2V ([**2178-1-20**]):  No acute cardiopulmonary pathology.
No acute abdominal pathology.
Status post urinary diversion with ileal conduit, with prominence of the lower ureters, unchanged since the prior study.
Fibroid uterus.
4.4  21  0.8 Comments: Glucose: If Fasting, 70-100 Normal, >125 Provisional Diabetes .
>100,000 ORGANISMS/ML..                                SENSITIVITIES: MIC expressed in MCG/ML  _________________________________________________________                              KLEBSIELLA PNEUMONIAE                              | AMPICILLIN/SULBACTAM--     4 S CEFAZOLIN-------------   <=4 S CEFEPIME--------------   <=1 S CEFTAZIDIME-----------   <=1 S CEFTRIAXONE-----------   <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------   <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN--------    64 I PIPERACILLIN/TAZO-----   <=4 S TOBRAMYCIN------------   <=1 S TRIMETHOPRIM/SULFA----  =>16 R  Brief Hospital Course: This is a 48-year-old female with spina bifida and long standing urostomy, mild mental retardation, and prior bullos skin lesions admitted [**2178-1-20**] for abdominal pain, suspected related to constipation; overnight with fever to 103 and development of bullous skin lesions, concerning for drug reaction.
BULLOUS HYPERSENSITIVITY DRUG REACTION:  New onset diffuse erythema and bullae in areas of friction noticed on hospital day 2, following fever to 103 evening prior.
Progressive throughout the day, with increasing blistering, particular in axilla, neck folds, back, thighs, and shins.
Recommended transfer to [**Hospital6 **] Burn Unit for close monitoring due to rapid progression of bullae.
Peripherals and PICC were unable to be placed due to patient's extensive blistering.
3) RESPIRATORY STATUS:  On the morning of [**1-13**], patient had increasing stridor and increased work of breathing in addition to angioedema.
She has required intubation in the past for respiratory decline in the setting of bullous hypersensitivity reaction.
She remains on neo 0.9, but this can probably be weaned prior to transfer or right afterward.
(5)  NON-EPILEPTIC SEIZURE DISORDER:  No concerning seizure activity during this hospital stay.
9. simethicone 80 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO QID (4 times a day) as needed for abdominal pain.
11. polyethylene glycol 3350 17 gram/dose Powder Sig: One (1) dose PO DAILY (Daily) as needed for constipation.
PO DAILY (Daily) as needed for constipation.
13. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation.
Discharge Disposition: Extended Care  Discharge Diagnosis: Abdominal pain - Constipation.
